Healthcare Services

Panic Attack Treatment Market Revenue Expected to Reach $7.96 Billion by 2030 with 17.3% CAGR

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Panic Attack Treatment Market By 2030 Starting From Its 2026 Size?

The panic attack treatment market size has experienced swift expansion in recent years. It is projected to grow from $3.58 billion in 2025 to $4.21 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.6%. Historically, the market’s growth was shaped by factors such as limited understanding of panic attack treatments, a reliance on traditional in-person therapy, the high cost of specialized medications, a fragmented mental healthcare infrastructure, and low adoption rates for digital therapy tools.

The market for panic attack treatments is projected to experience swift expansion over the coming years. This market is anticipated to reach $7.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.3%. Factors contributing to this growth during the forecast period include the greater adoption of telehealth platforms, the rise of virtual reality and digital therapeutics, the increasing occurrence of anxiety and panic disorders, progress in personalized medicine, and the broadening of online pharmacy and hospital distribution networks. Key trends observed within the forecast timeframe encompass the growing embrace of telepsychiatry and mobile health applications, the incorporation of virtual reality therapy specifically for panic disorders, the increased application of neurofeedback and biofeedback methods, the development of individualized medication plans, and the enlargement of mental healthcare centers and hospital services.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24356&type=smp

Which Market Drivers Are Supporting The Expansion Of The Panic Attack Treatment Market?

The rising occurrence of anxiety is anticipated to propel growth within the panic attack treatment market moving forward. Anxiety is a mental health condition characterized by persistent feelings of worry, nervousness, and fear, often accompanied by physical symptoms such as restlessness, rapid heartbeat, and difficulty concentrating. The demands of contemporary life contribute to escalating anxiety levels by creating continuous pressure for productivity, financial stability, and social success, leaving minimal time for rest or emotional recovery. Panic attack treatment addresses anxiety by offering effective solutions to alleviate symptoms, improve emotional well-being, and assist individuals in regaining control of their lives through personalized and timely interventions. For instance, in May 2024, according to the American Psychiatric Association (APA), a US-based medical specialty society representing psychiatrists nationwide, a growing percentage of U.S. adults report feeling more anxious, with 43% in 2024 expressing higher anxiety levels compared to 37% in 2023 and 32% in 2022. Therefore, the increasing prevalence of anxiety is driving the panic attack treatment market.

Which Segment Categories Define The Panic Attack Treatment Market?

The panic attack treatment market covered in this report is segmented –

1) By Treatment Type: Cognitive Behavioral Therapy (CBT), Medications, Other Treatment Types

2) By Drug Class: Antidepressants, Anti-Anxiety Drugs, Calcitonin Gene-Related Peptide (CGRP) Antagonists, Other Drug Classes

3) By Route Of Administration: Oral, Sublingual, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By Application: Hospitals, Mental Healthcare Centers, Other Applications

Subsegments:

1) By Cognitive Behavioral Therapy (CBT): Exposure Therapy, Dialectical Behavior Therapy (DBT), Acceptance And Commitment Therapy (ACT), Mindfulness-Based Cognitive Therapy (MBCT), Rational Emotive Behavior Therapy (REBT)

2) By Medications: Beta Blockers, Buspirone, Anticonvulsants, Atypical Antipsychotics, Herbal And Natural Supplements

3) By Other Treatment Types: Telepsychiatry, Biofeedback And Neurofeedback, Virtual Reality Therapy, Mobile Health Applications, Support Groups And Counseling Services

What Trends Are Projected To Affect The Panic Attack Treatment Market?

Companies operating in the panic attack treatment market are increasingly focusing on medical technology advancements, such as digital anxiety relief platforms, to improve the management of anxiety and panic attacks through accessible, technology-driven solutions. Digital anxiety relief platforms are technology-based applications or services designed to help individuals manage and reduce anxiety, offering tools like guided meditation, cognitive behavioral therapy modules, mood tracking, and relaxation exercises. For instance, in October 2024, CalmiGo, a US-based mental health startup, launched CalmiGo Plus, an advanced digital platform developed to assist users in managing anxiety and panic attacks more effectively. This platform features a patented, sensor-based exhaler device and a companion mobile application that utilizes gamification and personalized therapeutic techniques to enhance mental health outcomes. This innovation allows users to experience immediate, drug-free relief while also monitoring their progress over time, signifying a major leap forward in accessible and data-driven anxiety treatment solutions.

Who Are The Top Companies Competing In The Panic Attack Treatment Market?

Major companies operating in the panic attack treatment market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma, Lundbeck A/S, Torrent Pharmaceuticals Ltd., Merck & Co Inc., Bristol-Myers Squibb Company, Otsuka Pharmaceutical Co Ltd, Boehringer Ingelheim International GmbH, Allergan plc, Alkermes plc, Jazz Pharmaceuticals plc, Bayer AG, Amgen Inc., Cipla Limited

Read the full panic attack treatment market report here:

https://www.thebusinessresearchcompany.com/report/panic-attack-treatment-global-market-report

How Is The Panic Attack Treatment Market Distributed Across Key Geographic Regions?

North America was the largest region in the panic attack treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic attack treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Panic Attack Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24356&type=smp

Browse Through More Reports Similar to the Global Panic Attack Treatment Market 2026, By The Business Research Company

Pancreatic Cancer Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

Digestive Enzyme Global Market Report

https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report

Pancreatic Cancer Diagnostic Global Market Report

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-diagnostic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795